Shiao-Wen David Hsu, MD

Assistant Professor of Medicine
William Dalton Family Assistant Professor of Medical Oncology, in the School of Medicine
Member of the Duke Cancer Institute
Campus mail Dept Of Medicine, Box 3233, Durham, NC 27710
Phone (919) 681-3480
Email address shiaowen.hsu@duke.edu

Education and Training

  • Fellow in Hematology-Oncology, Medicine, Duke University, 2004 - 2007
  • Medical Resident, Medicine, University of Texas at Dallas, 2001 - 2004
  • M.D., University of North Carolina at Chapel Hill, 2001

Publications

Osada, T, Hsu, D, Hammond, S, Hobeika, A, Devi, G, Clay, TM, Lyerly, HK, and Morse, MA. "Metastatic colorectal cancer cells from patients previously treated with chemotherapy are sensitive to T-cell killing mediated by CEA/CD3-bispecific T-cell-engaging BiTE antibody." Br J Cancer 102, no. 1 (January 5, 2010): 124-133.

PMID
19953093
Full Text

Hsu, DS, Balakumaran, BS, Acharya, CR, Vlahovic, V, Walters, KS, Garman, K, Anders, C, Riedel, RF, Lancaster, J, Harpole, D, and al, E. "Pharmacogenomic strategies provide a rational approach to the treatment of cisplatin-resistant patients with advanced cancer (Journal of Clinical Oncology (2007) 25, (4350-4357))." Journal of Clinical Oncology 28, no. 35 (2010): 5229--.

Full Text

Balakumaran, BS, Porrello, A, Hsu, DS, Glover, W, Foye, A, Leung, JY, Sullivan, BA, Hahn, WC, Loda, M, and Febbo, PG. "MYC activity mitigates response to rapamycin in prostate cancer through eukaryotic initiation factor 4E-binding protein 1-mediated inhibition of autophagy." Cancer Research 69, no. 19 (October 1, 2009): 7803-7810.

Full Text

Balakumaran, BS, Porrello, A, Hsu, DS, Glover, W, Foye, A, Leung, JY, Sullivan, BA, Hahn, WC, Loda, M, and Febbo, PG. "MYC activity mitigates response to rapamycin in prostate cancer through eukaryotic initiation factor 4E-binding protein 1-mediated inhibition of autophagy." Cancer Res 69, no. 19 (October 1, 2009): 7803-7810.

PMID
19773438
Full Text

Hsu, DS, Acharya, CR, Balakumaran, BS, Riedel, RF, Kim, MK, Stevenson, M, Tuchman, S, Mukherjee, S, Barry, W, Dressman, HK, Nevins, JR, Powers, S, Mu, D, and Potti, A. "Characterizing the developmental pathways TTF-1, NKX2-8, and PAX9 in lung cancer." Proc Natl Acad Sci U S A 106, no. 13 (March 31, 2009): 5312-5317.

PMID
19279207
Full Text

Garman, KS, Acharya, CR, Edelman, E, Grade, M, Gaedcke, J, Sud, S, Barry, W, Diehl, AM, Provenzale, D, Ginsburg, GS, Ghadimi, BM, Ried, T, Nevins, JR, Mukherjee, S, Hsu, D, and Potti, A. "Erratum: A genomic approach to colon cancer risk stratification yields biologic insights into therapeutic opportunities (Proceedings of the National Academy of Sciences of the United States of America (2008) 105:49 (19432-19437) Doi: 10.1073/pnas.0806674105)." Proceedings of the National Academy of Sciences of the United States of America 106, no. 16 (2009): 6878--.

Full Text

Hsu, DS, Morse, M, Clay, T, Devi, G, and Lyerly, HK. "Immune Cells and the Tumor Microenvironment." 818-829. 2009.

Full Text

Garman, KS, Acharya, CR, Edelman, E, Grade, M, Gaedcke, J, Sud, S, Barry, W, Diehl, AM, Provenzale, D, Ginsburg, GS, Ghadimi, BM, Ried, T, Nevins, JR, Mukherjee, S, Hsu, D, and Potti, A. "A genomic approach to colon cancer risk stratification yields biologic insights into therapeutic opportunities." Proc Natl Acad Sci U S A 105, no. 49 (December 9, 2008): 19432-19437.

PMID
19050079
Full Text

Riedel, RF, Porrello, A, Pontzer, E, Chenette, EJ, Hsu, DS, Balakumaran, B, Potti, A, Nevins, J, and Febbo, PG. "A genomic approach to identify molecular pathways associated with chemotherapy resistance." Mol Cancer Ther 7, no. 10 (October 2008): 3141-3149.

PMID
18852117
Full Text

Anders, CK, Hsu, DS, Broadwater, G, Acharya, CR, Foekens, JA, Zhang, Y, Wang, Y, Marcom, PK, Marks, JR, Febbo, PG, Nevins, JR, Potti, A, and Blackwell, KL. "Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression." J Clin Oncol 26, no. 20 (July 10, 2008): 3324-3330.

PMID
18612148
Full Text

Pages